A carregar...
The DEK oncogene is a target of steroid hormone receptor signaling in breast cancer.
Expression of estrogen and progesterone hormone receptors indicates a favorable prognosis due to the successful use of hormonal therapies such as tamoxifen and aromatase inhibitors. Unfortunately, 15-20% of patients will experience breast cancer recurrence despite continued use of tamoxifen. Drug re...
Na minha lista:
Main Authors: | , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Public Library of Science (PLoS)
2012-01-01
|
Colecção: | PLoS ONE |
Acesso em linha: | http://europepmc.org/articles/PMC3468546?pdf=render |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|